Minimal-Incision Technique With Modified Tracking Pin Placement Versus Standard Robotic-Assisted Total Knee Arthroplasty (MISI)
Comparison of a Minimal Incision and Minimal Soft-Tissue Injury (MISI) Technique Versus the Standard Technique in Robotic-Assisted Total Knee Arthroplasty: A Randomized Controlled Trial
Visão geral do estudo
Status
Status
Condições
Condições
Intervenção / Tratamento
Intervenção / Tratamento
Descrição detalhada
Robotic-assisted total knee arthroplasty requires surgical exposure and placement of tracking pins. Conventional techniques may involve a relatively long incision, broader soft-tissue dissection, and diaphyseal pin insertion. The MISI technique was developed to reduce surgical invasiveness through a shorter incision, limited soft-tissue dissection, and modified tracking pin placement that avoids diaphyseal pin insertion.
Participants will be randomly assigned to the MISI or standard technique in a 1:1 ratio. Clinical evaluations will be performed during follow-up for up to 12 months. The study will assess whether the MISI technique improves scar-related outcomes and early recovery without increasing procedure-related complications.
Tipo de estudo
Tipo de estudo
Inscrição (Estimado)
Inscrição
Estágio
Estágio
- Não aplicável
Contactos e Locais
Contato de estudo
Contato de estudo
- Nome: Ho-Jung Jung, MD, PhD
- Número de telefone: 82-02-819-5165
- E-mail: hodge@hallym.or.kr
Locais de estudo
-
-
-
Seoul, Coréia do Sul
- Hallym University Kangnam Sacred Heart Hospital
-
Contato:
- Ho-Jung Jung, MD, PhD
- Número de telefone: 82-02-819-5165
- E-mail: hodge@hallym.or.kr
-
-
Critérios de participação
Critérios de elegibilidade
Critérios de elegibilidade
Idades elegíveis para estudo
- Adulto
- Adulto mais velho
Aceita Voluntários Saudáveis
Descrição
Inclusion Criteria:
- Adults aged 18 years or older
- Degenerative knee osteoarthritis requiring robotic-assisted total knee arthroplasty
- Body mass index below 30 kg/m²
- Preoperative knee flexion of 90 degrees or greater
- Ability to understand the study information and provide written informed consent
Exclusion Criteria:
- Skin lesions or conditions that may adversely affect wound healing
- Previous intra-articular surgery of the affected knee
- Inflammatory arthritis, including rheumatoid arthritis
- Severe hepatic or renal disease associated with poor general health
- Comorbid conditions that may substantially affect mobility, including Parkinson disease, sequelae of poliomyelitis, or stroke
- Inability or unwillingness to complete the required follow-up
- Any medical or other condition that, in the investigator's judgment, makes participation inappropriate
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Tratamento
- Alocação: Randomizado
- Modelo Intervencional: Atribuição Paralela
- Mascaramento: Solteiro
Número de braços
Armas e Intervenções
Grupo de Participantes / BraçoGrupo de Participantes / Braço |
Intervenção / TratamentoIntervenção / Tratamento |
|---|---|
|
Experimental: MISI tenchique
Participants will undergo robotic-assisted total knee arthroplasty using the minimal incision and minimal soft-tissue injury (MISI) technique.
The procedure uses an approximately 10-cm main incision with limited soft-tissue dissection.
Two femoral tracking pins are inserted through the main incision, and one tibial tracking pin is inserted through an additional approximately 5-mm incision.
|
Robot-assisted total knee arthroplasty performed using an approximately 10-cm main incision, limited soft-tissue dissection, two femoral tracking pins inserted through the main incision, and one tibial tracking pin inserted through an additional approximately 5-mm incision.
|
|
Comparador Ativo: Standard technique
Participants will undergo robotic-assisted total knee arthroplasty using the standard surgical technique.
Tracking arrays are secured using the conventional pin placement method, with four tracking pins placed in the femoral and tibial regions and an additional femoral incision.
|
Robot-assisted total knee arthroplasty performed using the standard incision and soft-tissue exposure, with conventional placement of four tracking pins in the femoral and tibial regions and an additional femoral incision.
|
O que o estudo está medindo?
Medidas de resultados primários
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Patient and Observer Scar Assessment Scale Score
Prazo: 3 months after surgery
|
The combined Patient and Observer Scar Assessment Scale (POSAS) score is calculated by summing the total Patient Scale score and the total Observer Scale score.
Each scale consists of six items rated from 1 to 10, resulting in a score of 6 to 60 for each scale and a combined score ranging from 12 to 120.
Higher scores indicate poorer scar quality.
The Observer Scale will be completed by an independent outcome assessor blinded to treatment allocation.
|
3 months after surgery
|
Medidas de resultados secundários
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Patient and Observer Scar Assessment Scale Score
Prazo: 3 and 6 weeks after surgery
|
The combined Patient and Observer Scar Assessment Scale (POSAS) score is calculated by summing the total Patient Scale score and the total Observer Scale score.
Each scale consists of six items rated from 1 to 10, resulting in a score of 6 to 60 for each scale and a combined score ranging from 12 to 120.
Higher scores indicate poorer scar quality.
The Observer Scale will be completed by an independent outcome assessor blinded to treatment allocation.
|
3 and 6 weeks after surgery
|
|
Main Surgical Incision Length
Prazo: During surgery and on postoperative day 1
|
The length of the main surgical incision will be measured in centimeters.
The initial incision length will be measured immediately after the skin incision with the knee in extension, and the final incision length will be measured before wound closure.
The incision length will also be evaluated on postoperative day 1.
Separate tracking pin-site incisions will not be included.
|
During surgery and on postoperative day 1
|
|
Intraoperative Incision Stretching Index
Prazo: During surgery
|
The incision stretching index is calculated as the maximum length of the main incision during knee flexion and maximal surgical retraction divided by the initial incision length measured with the knee in extension.
A value of 1 indicates no stretching, and higher values indicate greater intraoperative stretching of the incision and surrounding soft tissue.
|
During surgery
|
|
Postoperative Gauze Oozing Grade
Prazo: Postoperative days 1, 2, 4, and 6
|
Postoperative wound oozing will be assessed according to the amount of blood or exudate visible on the surgical dressing using a prespecified ordinal grading scale.
Higher grades indicate more extensive wound oozing.
|
Postoperative days 1, 2, 4, and 6
|
|
Thigh Pain at Rest on the Numeric Rating Scale
Prazo: Postoperative days 1, 2, 4, and 6
|
Participants will rate thigh pain at rest using an 11-point numeric rating scale ranging from 0 to 10, where 0 indicates no pain and 10 indicates the worst imaginable pain.
|
Postoperative days 1, 2, 4, and 6
|
|
Thigh Pain During Active Hip Flexion on the Numeric Rating Scale
Prazo: Postoperative days 1, 2, 4, and 6
|
Participants will rate thigh pain during active hip flexion while maintaining knee extension and without external resistance.
Pain will be assessed using an 11-point numeric rating scale ranging from 0 to 10, where 0 indicates no pain and 10 indicates the worst imaginable pain.
|
Postoperative days 1, 2, 4, and 6
|
|
Tenderness at the Standardized Tracking Pin-Site Location
Prazo: Postoperative days 1, 2, 4, and 6
|
Tenderness elicited by palpation at a prespecified standardized anatomical location corresponding to the tracking pin region will be rated using an 11-point numeric rating scale ranging from 0 to 10, where 0 indicates no tenderness and 10 indicates the worst imaginable tenderness.
|
Postoperative days 1, 2, 4, and 6
|
|
Ability to Perform Straight-Leg Raising
Prazo: Postoperative days 1, 2, 4, and 6
|
The participant's ability to independently raise the operated lower extremity while maintaining knee extension will be recorded as a binary outcome: able or unable to perform straight-leg raising.
The number and proportion of participants able to perform the test will be compared between groups.
|
Postoperative days 1, 2, 4, and 6
|
|
Pain During the Resisted Straight-Leg-Raising Test
Prazo: Postoperative days 1, 2, 4, and 6
|
Pain during resisted straight-leg raising will be assessed using a 100-mm visual analog scale, where 0 mm indicates no pain and 100 mm indicates the worst imaginable pain.
|
Postoperative days 1, 2, 4, and 6
|
|
Incidence of Tracking Pin-Site Complications
Prazo: Postoperative days 1, 2, 4, and 6 and postoperative week 3
|
Tracking pin sites will be examined for complications, including erythema, swelling, wound drainage, infection, and pin-related fracture.
The occurrence of one or more prespecified pin-site complications will be recorded as a binary outcome, and the number and proportion of participants with any complication will be reported.
|
Postoperative days 1, 2, 4, and 6 and postoperative week 3
|
|
Forgotten Joint Score-12
Prazo: 6 and 12 months after surgery
|
The Forgotten Joint Score-12 is a 12-item patient-reported questionnaire assessing awareness of the operated knee during daily activities.
Scores are transformed to a scale ranging from 0 to 100, with higher scores indicating less awareness of the artificial joint and a better outcome.
|
6 and 12 months after surgery
|
|
Western Ontario and McMaster Universities Osteoarthritis Index
Prazo: 6 and 12 months after surgery
|
The Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) assesses knee pain, stiffness, and physical function.
The 24 items are scored using a 5-point Likert scale, producing a total score ranging from 0 to 96.
Higher scores indicate more severe symptoms and poorer physical function.
|
6 and 12 months after surgery
|
Colaboradores e Investigadores
Patrocinador
Patrocinador
Investigadores
Investigadores
- Investigador principal: Joong-Il Kim, MD, PhD, Hallym University Kangnam Sacred Heart Hospital
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Estimado)
Início do estudo
Conclusão Primária (Estimado)
Conclusão Primária
Conclusão do estudo (Estimado)
Conclusão do estudo
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Primeira postagem
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última Atualização Postada
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Última verificação
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Outros números de identificação do estudo
Outros números de identificação do estudo
- HKS 2026-05-024
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .